Want to see TSE:DRUG full AI Analyst Report?
Bright Minds Biosciences (DRUG) Financial Statements
Bright Minds Biosciences Financial Overview
Bright Minds Biosciences's market cap is currently $757.87M. The company's EPS TTM is $-2.76; its P/E ratio is -26.55; Bright Minds Biosciences is estimated to report earnings on December 17, 2026, and the estimated EPS forecast is $-1.61. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Dec 24 | Sep 23 | Sep 22 | Sep 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -13.94M | $ -2.82M | $ -7.39M | $ -14.98M | $ -8.62M |
| EBITDA | $ -12.15M | $ -2.73M | $ -7.30M | $ -14.96M | $ -27.64K |
| Net Income | $ -12.23M | $ -2.80M | $ -7.37M | $ -14.96M | $ -8.65M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 82.91M | $ 5.72M | $ 6.75M | $ 11.63M | $ 19.76M |
| Total Assets | $ 84.42M | $ 6.10M | $ 6.88M | $ 12.09M | $ 20.04M |
| Total Debt | $ 125.78K | $ 118.96K | $ 73.55K | $ 139.91K | $ 0.00 |
| Net Debt | $ -82.78M | $ -5.60M | $ -6.67M | $ -11.49M | $ -19.76M |
| Total Liabilities | $ 2.38M | $ 568.26K | $ 280.86K | $ 1.54M | $ 638.57K |
| Stockholders' Equity | $ 82.04M | $ 5.54M | $ 6.60M | $ 10.54M | $ 19.40M |
| Cash Flow | |||||
| Free Cash Flow | $ -8.69M | $ -1.85M | $ -7.02M | $ -13.59M | $ -7.32M |
| Operating Cash Flow | $ -8.69M | $ -1.85M | $ -7.02M | $ -13.59M | $ -7.32M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 85.57M | $ 810.57K | $ 2.19M | $ 5.20M | $ 26.06M |
Currency in CAD